30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Greenwich Lifesciences Inc (GLSI)

Track

The most recent insider trading activity occurred on January 13, 2026, with CEO and CFO Patel Snehal executing a buy transaction of 1,800 shares valued at $53,694. This follows a series of consistent buy transactions by the same insider throughout late 2025 and early 2026, indicating sustained confidence.
Stock chart
Ticker: GLSI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Patel Snehal
CEO and CFO
1 purchase — total 53,694 USD
Buy 13 Jan 2026
Value US$4,716,003.75 | Price 292.65 | Shares 42,210
Buy 12 Jan 2026
Value US$1,379,274.52 | Price 56.85 | Shares 34,247
Buy 31 Dec 2025
Value US$91,848.00 | Price 21.36 | Shares 4,300
Buy 30 Dec 2025
Value US$63,017.00 | Price 21.73 | Shares 2,900
Buy 18 Dec 2025
Value US$51,742.00 | Price 12.62 | Shares 4,100
Buy 25 Nov 2025
Value US$38,502.00 | Price 8.37 | Shares 4,600
Buy 7 Nov 2025
Value US$89,358.00 | Price 8.43 | Shares 10,600
Buy 31 Oct 2025
Value US$21,298.00 | Price 9.26 | Shares 2,300
Buy 25 Apr 2025
Value US$35,568.00 | Price 9.88 | Shares 3,600
Buy 17 Apr 2025
Value US$48,492.00 | Price 8.98 | Shares 5,400
Buy 7 Apr 2025
Value US$32,760.00 | Price 9.10 | Shares 3,600
Buy 4 Apr 2025
Value US$48,015.00 | Price 8.73 | Shares 5,500
Buy 10 Jan 2025
Value US$31,275.00 | Price 12.51 | Shares 2,500
Buy 7 Jan 2025
Value US$24,750.00 | Price 13.75 | Shares 1,800
Buy 6 Jan 2025
Value US$14,641.00 | Price 13.31 | Shares 1,100
Buy 3 Jan 2025
Value US$44,030.00 | Price 12.95 | Shares 3,400
Buy 2 Jan 2025
Value US$23,940.00 | Price 11.97 | Shares 2,000
Buy 31 Dec 2024
Value US$27,264.00 | Price 11.36 | Shares 2,400
Buy 30 Dec 2024
Value US$35,584.00 | Price 11.12 | Shares 3,200
Buy 21 Nov 2024
Value US$12,910.00 | Price 12.91 | Shares 1,000
Buy 26 Sep 2024
Value US$21,945.00 | Price 14.63 | Shares 1,500
Buy 12 Aug 2024
Value US$11,080.00 | Price 13.85 | Shares 800
Buy 6 Aug 2024
Value US$27,620.00 | Price 13.81 | Shares 2,000
Buy 5 Aug 2024
Value US$72,490.00 | Price 13.18 | Shares 5,500
Buy 2 Aug 2024
Value US$15,150.00 | Price 15.15 | Shares 1,000
Buy 23 Jul 2024
Value US$23,835.00 | Price 15.89 | Shares 1,500
Buy 18 Jul 2024
Value US$16,000.00 | Price 16.00 | Shares 1,000
Buy 13 Jun 2024
Value US$2,499,997.50 | Price 14.30 | Shares 174,825
Buy 1 Apr 2024
Value US$57,240.00 | Price 19.08 | Shares 3,000
Buy 22 Mar 2024
Value US$49,950.00 | Price 19.98 | Shares 2,500
Buy 20 Mar 2024
Value US$26,520.00 | Price 17.68 | Shares 1,500
Buy 5 Mar 2024
Value US$380,945.00 | Price 12.49 | Shares 30,500
Buy 4 Mar 2024
Value US$53,423.00 | Price 13.03 | Shares 4,100
Buy 16 Feb 2024
Value US$120,528.00 | Price 11.16 | Shares 10,800
Buy 15 Feb 2024
Value US$140,589.00 | Price 11.07 | Shares 12,700
Buy 10 Nov 2023
Value US$50,837.50 | Price 10.17 | Shares 5,000
Buy 3 Nov 2023
Value US$31,885.00 | Price 9.11 | Shares 3,500
Buy 27 Oct 2023
Value US$4,285.00 | Price 8.57 | Shares 500
Buy 26 Oct 2023
Value US$19,925.00 | Price 7.97 | Shares 2,500
Buy 25 Oct 2023
Value US$19,775.00 | Price 7.91 | Shares 2,500
Buy 10 Oct 2023
Value US$9,070.00 | Price 9.07 | Shares 1,000
Buy 4 Oct 2023
Value US$17,260.00 | Price 8.63 | Shares 2,000
Buy 26 Sep 2023
Value US$5,226.00 | Price 8.71 | Shares 600
Buy 19 Sep 2023
Value US$35,800.00 | Price 8.95 | Shares 4,000
Buy 11 Sep 2023
Value US$9,480.00 | Price 9.48 | Shares 1,000
Buy 22 Aug 2023
Value US$9,970.00 | Price 9.97 | Shares 1,000
Buy 4 Aug 2023
Value US$21,100.00 | Price 10.55 | Shares 2,000
Buy 21 Jul 2023
Value US$9,200.00 | Price 9.20 | Shares 1,000
Buy 13 Jul 2023
Value US$2,372.50 | Price 9.49 | Shares 250
Buy 17 May 2023
Value US$11,690.00 | Price 11.69 | Shares 1,000
Buy 28 Apr 2023
Value US$2,805.00 | Price 11.22 | Shares 250
Buy 19 Apr 2023
Value US$77,700.00 | Price 11.10 | Shares 7,000
Buy 18 Apr 2023
Value US$22,240.00 | Price 11.12 | Shares 2,000
Buy 11 Apr 2023
Value US$62,100.00 | Price 12.42 | Shares 5,000
Buy 11 Apr 2023
Value US$11,870.00 | Price 11.87 | Shares 1,000
Buy 15 Mar 2023
Value US$3,177.50 | Price 12.71 | Shares 250
Buy 10 Mar 2023
Value US$12,120.00 | Price 12.12 | Shares 1,000
Buy 24 Feb 2023
Value US$3,848.75 | Price 15.40 | Shares 250
Buy 17 Feb 2023
Value US$9,918.00 | Price 16.53 | Shares 600
Buy 10 Feb 2023
Value US$18,680.00 | Price 18.68 | Shares 1,000
Buy 3 Feb 2023
Value US$5,210.00 | Price 20.84 | Shares 250
Buy 27 Jan 2023
Value US$38,700.00 | Price 19.35 | Shares 2,000
Buy 27 Jan 2023
Value US$4,800.00 | Price 19.20 | Shares 250
Buy 20 Jan 2023
Value US$26,055.00 | Price 17.37 | Shares 1,500
Buy 13 Jan 2023
Value US$4,125.00 | Price 16.50 | Shares 250
Buy 6 Jan 2023
Value US$22,770.00 | Price 15.18 | Shares 1,500
Buy 29 Dec 2022
Value US$60,760.00 | Price 15.19 | Shares 4,000
Buy 16 Dec 2022
Value US$3,235.00 | Price 12.94 | Shares 250
Buy 16 Dec 2022
Value US$13,010.00 | Price 13.01 | Shares 1,000
Buy 9 Dec 2022
Value US$26,220.00 | Price 13.11 | Shares 2,000
Buy 2 Dec 2022
Value US$13,840.00 | Price 13.84 | Shares 1,000
Buy 2 Dec 2022
Value US$3,495.00 | Price 13.98 | Shares 250
Buy 2 Nov 2022
Value US$17,580.00 | Price 8.79 | Shares 2,000
Buy 14 Oct 2022
Value US$29,250.00 | Price 9.75 | Shares 3,000
Buy 7 Oct 2022
Value US$19,440.00 | Price 9.72 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-15 2026-01-13 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
42,210 -31.7%
292.65
US$4,716,004 		42,210 -31.7% 292.65 US$4,716,004
2026-01-14 2026-01-12 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
34,247 +14.4%
56.85
US$1,379,275 		34,247 +14.4% 56.85 US$1,379,275
2026-01-05 2025-12-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
36,342 +43.3%
155.59
US$2,254,476 		36,342 +43.3% 155.59 US$2,254,476
2026-01-02 2025-12-30 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,900 +0.1%
21.73
US$63,017 		2,900 +0.1% 21.73 US$63,017
2025-12-19 2025-12-18 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,100 +0.1%
12.62
US$51,742 		4,100 +0.1% 12.62 US$51,742
2025-11-28 2025-11-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,600 +0.1%
8.37
US$38,502 		4,600 +0.1% 8.37 US$38,502
2025-11-12 2025-11-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
10,600 +0.2%
8.43
US$89,358 		10,600 +0.2% 8.43 US$89,358
2025-11-04 2025-10-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,300 +0.0%
9.26
US$21,298 		2,300 +0.0% 9.26 US$21,298
2025-04-29 2025-04-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,600 +0.1%
9.88
US$35,568 		3,600 +0.1% 9.88 US$35,568
2025-04-22 2025-04-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,400 +0.1%
8.98
US$48,492 		5,400 +0.1% 8.98 US$48,492
2025-04-08 2025-04-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,600 +0.1%
9.10
US$32,760 		3,600 +0.1% 9.10 US$32,760
2025-04-07 2025-04-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,500 +0.1%
8.73
US$48,015 		5,500 +0.1% 8.73 US$48,015
2025-01-13 2025-01-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
12.51
US$31,275 		2,500 +0.0% 12.51 US$31,275
2025-01-08 2025-01-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,800 +0.0%
13.75
US$24,750 		1,800 +0.0% 13.75 US$24,750
2025-01-08 2025-01-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,100 +0.0%
13.31
US$14,641 		1,100 +0.0% 13.31 US$14,641
2025-01-07 2025-01-03 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,400 +0.1%
12.95
US$44,030 		3,400 +0.1% 12.95 US$44,030
2025-01-06 2025-01-02 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
11.97
US$23,940 		2,000 +0.0% 11.97 US$23,940
2025-01-03 2024-12-31 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,400 +0.0%
11.36
US$27,264 		2,400 +0.0% 11.36 US$27,264
2025-01-02 2024-12-30 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,200 +0.1%
11.12
US$35,584 		3,200 +0.1% 11.12 US$35,584
2024-11-25 2024-11-21 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
12.91
US$12,910 		1,000 +0.4% 12.91 US$12,910
2024-09-30 2024-09-26 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
14.63
US$21,945 		1,500 +0.0% 14.63 US$21,945
2024-09-16 2024-08-12 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
800 +0.3%
13.85
US$11,080 		800 +0.3% 13.85 US$11,080
2024-08-08 2024-08-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
13.81
US$27,620 		2,000 +0.0% 13.81 US$27,620
2024-08-07 2024-08-05 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,500 +0.1%
13.18
US$72,490 		5,500 +0.1% 13.18 US$72,490
2024-08-05 2024-08-02 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
15.15
US$15,150 		1,000 +0.4% 15.15 US$15,150
2024-07-24 2024-07-23 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
15.89
US$23,835 		1,500 +0.0% 15.89 US$23,835
2024-07-22 2024-07-18 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
16.00
US$16,000 		1,000 +0.4% 16.00 US$16,000
2024-06-17 2024-06-13 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
174,825 +3.3%
14.30
US$2,499,998 		174,825 +3.3% 14.30 US$2,499,998
2024-04-03 2024-04-01 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,000 +0.1%
19.08
US$57,240 		3,000 +0.1% 19.08 US$57,240
2024-03-26 2024-03-22 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
19.98
US$49,950 		2,500 +0.0% 19.98 US$49,950
2024-03-22 2024-03-20 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.0%
17.68
US$26,520 		1,500 +0.0% 17.68 US$26,520
2024-03-07 2024-03-05 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
30,500 +0.6%
12.49
US$380,945 		30,500 +0.6% 12.49 US$380,945
2024-03-06 2024-03-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,100 +0.1%
13.03
US$53,423 		4,100 +0.1% 13.03 US$53,423
2024-02-21 2024-02-16 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
10,800 +0.2%
11.16
US$120,528 		10,800 +0.2% 11.16 US$120,528
2024-02-20 2024-02-15 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
12,700 +0.2%
11.07
US$140,589 		12,700 +0.2% 11.07 US$140,589
2023-11-14 2023-11-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,000 +0.1%
10.17
US$50,838 		5,000 +0.1% 10.17 US$50,838
2023-11-07 2023-11-03 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,500 +0.1%
9.11
US$31,885 		3,500 +0.1% 9.11 US$31,885
2023-10-31 2023-10-27 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
500 +0.2%
8.57
US$4,285 		500 +0.2% 8.57 US$4,285
2023-10-30 2023-10-26 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
7.97
US$19,925 		2,500 +0.0% 7.97 US$19,925
2023-10-27 2023-10-25 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,500 +0.0%
7.91
US$19,775 		2,500 +0.0% 7.91 US$19,775
2023-10-12 2023-10-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.07
US$9,070 		1,000 +0.0% 9.07 US$9,070
2023-10-05 2023-10-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
8.63
US$17,260 		2,000 +0.0% 8.63 US$17,260
2023-09-28 2023-09-26 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
600 +0.2%
8.71
US$5,226 		600 +0.2% 8.71 US$5,226
2023-09-21 2023-09-19 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,000 +0.1%
8.95
US$35,800 		4,000 +0.1% 8.95 US$35,800
2023-09-13 2023-09-11 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.48
US$9,480 		1,000 +0.0% 9.48 US$9,480
2023-08-24 2023-08-22 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.97
US$9,970 		1,000 +0.0% 9.97 US$9,970
2023-08-08 2023-08-04 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
10.55
US$21,100 		2,000 +0.0% 10.55 US$21,100
2023-07-25 2023-07-21 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
9.20
US$9,200 		1,000 +0.0% 9.20 US$9,200
2023-07-17 2023-07-13 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
9.49
US$2,372 		250 +0.1% 9.49 US$2,372
2023-05-18 2023-05-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
11.69
US$11,690 		1,000 +0.0% 11.69 US$11,690
2023-05-02 2023-04-28 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
11.22
US$2,805 		250 +0.1% 11.22 US$2,805
2023-04-21 2023-04-19 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
7,000 +0.1%
11.10
US$77,700 		7,000 +0.1% 11.10 US$77,700
2023-04-20 2023-04-18 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.0%
11.12
US$22,240 		2,000 +0.0% 11.12 US$22,240
2023-04-12 2023-04-11 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
5,000 +0.1%
12.42
US$62,100 		5,000 +0.1% 12.42 US$62,100
2023-04-12 2023-04-11 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
1,000 +0.4%
11.87
US$11,870 		1,000 +0.4% 11.87 US$11,870
2023-03-16 2023-03-15 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
12.71
US$3,178 		250 +0.1% 12.71 US$3,178
2023-03-13 2023-03-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
12.12
US$12,120 		1,000 +0.0% 12.12 US$12,120
2023-02-28 2023-02-24 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
15.40
US$3,849 		250 +0.1% 15.40 US$3,849
2023-02-22 2023-02-17 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
600 +0.0%
16.53
US$9,918 		600 +0.0% 16.53 US$9,918
2023-02-14 2023-02-10 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
18.68
US$18,680 		1,000 +0.0% 18.68 US$18,680
2023-02-07 2023-02-03 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
20.84
US$5,210 		250 +0.1% 20.84 US$5,210
2023-01-31 2023-01-27 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
19.35
US$38,700 		2,000 +0.1% 19.35 US$38,700
2023-01-30 2023-01-27 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
19.20
US$4,800 		250 +0.1% 19.20 US$4,800
2023-01-24 2023-01-20 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.1%
17.37
US$26,055 		1,500 +0.1% 17.37 US$26,055
2023-01-17 2023-01-13 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
16.50
US$4,125 		250 +0.1% 16.50 US$4,125
2023-01-10 2023-01-06 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,500 +0.1%
15.18
US$22,770 		1,500 +0.1% 15.18 US$22,770
2023-01-03 2022-12-29 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
4,000 +0.1%
15.19
US$60,760 		4,000 +0.1% 15.19 US$60,760
2022-12-20 2022-12-16 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
12.94
US$3,235 		250 +0.1% 12.94 US$3,235
2022-12-20 2022-12-16 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
13.01
US$13,010 		1,000 +0.0% 13.01 US$13,010
2022-12-13 2022-12-09 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
13.11
US$26,220 		2,000 +0.1% 13.11 US$26,220
2022-12-06 2022-12-02 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
1,000 +0.0%
13.84
US$13,840 		1,000 +0.0% 13.84 US$13,840
2022-12-06 2022-12-02 B Purchase
2.4
Thompson Jaye

VP Clinical Reg Affairs

Officer
250 +0.1%
13.98
US$3,495 		250 +0.1% 13.98 US$3,495
2022-11-04 2022-11-02 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
8.79
US$17,580 		2,000 +0.1% 8.79 US$17,580
2022-10-17 2022-10-14 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
3,000 +0.1%
9.75
US$29,250 		3,000 +0.1% 9.75 US$29,250
2022-10-11 2022-10-07 B Purchase
3.8
Patel Snehal

CEO and CFO

Executive Director Large shareholder
2,000 +0.1%
9.72
US$19,440 		2,000 +0.1% 9.72 US$19,440
Explore more

More insider trading research around Greenwich Lifesciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America